Acadia Healthcare (NASDAQ:ACHC) PT Lowered to $91.00 at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its price target reduced by Barclays from $100.00 to $91.00 in a research report report published on Thursday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other equities analysts have also recently commented on the stock. Stephens upgraded shares of Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 target price for the company in a research report on Friday, January 5th. Royal Bank of Canada reaffirmed an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a report on Wednesday, February 28th. Cantor Fitzgerald reiterated a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, TheStreet upgraded shares of Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus price target of $88.89.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $66.12 on Thursday. The company has a 50-day simple moving average of $76.77 and a two-hundred day simple moving average of $77.52. Acadia Healthcare has a twelve month low of $64.74 and a twelve month high of $87.77. The stock has a market capitalization of $6.11 billion, a price-to-earnings ratio of -472.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.75 earnings per share. Analysts forecast that Acadia Healthcare will post 3.56 EPS for the current year.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. Quent Capital LLC lifted its position in shares of Acadia Healthcare by 8.1% in the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after purchasing an additional 284 shares during the period. BNP Paribas Financial Markets boosted its position in Acadia Healthcare by 77.1% during the first quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock valued at $1,700,000 after acquiring an additional 9,342 shares during the last quarter. Peterson Wealth Services acquired a new stake in Acadia Healthcare during the 1st quarter worth about $2,739,000. Retirement Systems of Alabama lifted its stake in shares of Acadia Healthcare by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock valued at $9,174,000 after purchasing an additional 303 shares during the period. Finally, OFI Invest Asset Management grew its stake in Acadia Healthcare by 2.5% during the first quarter. OFI Invest Asset Management now owns 164,427 shares of the company’s stock worth $12,061,000 after purchasing an additional 4,013 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.